Compare CORT & AGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | AGCO |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 8.5B |
| IPO Year | N/A | 1992 |
| Metric | CORT | AGCO |
|---|---|---|
| Price | $36.38 | $113.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | $111.00 | ★ $112.10 |
| AVG Volume (30 Days) | ★ 3.0M | 727.9K |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | N/A | ★ 121.88 |
| EPS | 0.87 | ★ 5.02 |
| Revenue | $741,172,000.00 | ★ $10,049,100,000.00 |
| Revenue This Year | $21.70 | N/A |
| Revenue Next Year | $30.13 | $3.00 |
| P/E Ratio | $40.40 | ★ $21.90 |
| Revenue Growth | ★ 17.92 | N/A |
| 52 Week Low | $32.99 | $73.79 |
| 52 Week High | $117.33 | $121.16 |
| Indicator | CORT | AGCO |
|---|---|---|
| Relative Strength Index (RSI) | 24.35 | 61.16 |
| Support Level | $34.06 | $109.35 |
| Resistance Level | $37.48 | $118.21 |
| Average True Range (ATR) | 2.23 | 3.60 |
| MACD | -0.12 | 0.36 |
| Stochastic Oscillator | 58.56 | 67.43 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.